34643082|t|Structural Modification, In Vitro, In Vivo, Ex Vivo, and In Silico Exploration of Pyrimidine and Pyrrolidine Cores for Targeting Enzymes Associated with Neuroinflammation and Cholinergic Deficit in Alzheimer's Disease.
34643082|a|To obtain a multipotent framework that can target simultaneously COX-2, 5-LOX, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) to treat neuroinflammation, a series of derivatives containing pyrimidine and pyrrolidine cores were rationally synthesized and evaluated. Pyrazoline-pyrimidine hybrid (23g), (3-acetylcoumarin derivative of pyrrolidin-1-yl)benzenesulfonamide (27), and tacrine derivatives of (pyrrolidin-1-yl)benzenesulfonamide (31, 38) displayed excellent in vitro COX-2 inhibition having IC50 value in the nanomolar range. Tacrine-pyrrolidine hybrids 36 and 38, and tacrine-pyrimidine hybrid (46) emerged as the most potent eeAChE inhibitors with IC50 values of 23, 16, and 2 nM, respectively. However, compounds 27, 31, and 38 possessed excellent simultaneous and balanced inhibitory activity against all of the four tested targets and thus emerged as optimal multipotent hybrid compounds among all of the synthesized series of the compounds. In the ex vivo, transgenic animal models treated with compounds 36 and 46 displayed a significant decline in both AChE and BChE potentials in the hippocampus and cortical tissues. In anti-inflammatory activities, animals treated with compounds 36 and 46 displayed a significant % inhibition of edema induced by carrageenan and arachidonic acid. Biochemical analysis and histopathological examination of mice liver indicate that tacrine derivatives are devoid of hepatotoxicity and neurotoxicity against SH-SY5Y neuroblastoma cell lines. In vivo acute toxicity study showed the safety of synthesized compounds up to 1000 mg/kg dose. The inhibitory manner of interaction of these potent drugs on all of the studied in vitro targets was confirmed by molecular docking investigations.
34643082	82	92	Pyrimidine	Chemical	MESH:C030986
34643082	97	108	Pyrrolidine	Chemical	MESH:C032519
34643082	153	170	Neuroinflammation	Disease	MESH:D000090862
34643082	187	194	Deficit	Disease	MESH:D009461
34643082	198	217	Alzheimer's Disease	Disease	MESH:D000544
34643082	284	289	COX-2	Gene	4513
34643082	291	296	5-LOX	Gene	240
34643082	298	318	acetylcholinesterase	Gene	43
34643082	320	324	AChE	Gene	43
34643082	331	352	butyrylcholinesterase	Gene	590
34643082	354	358	BChE	Gene	590
34643082	369	386	neuroinflammation	Disease	MESH:D000090862
34643082	423	433	pyrimidine	Chemical	MESH:C030986
34643082	438	449	pyrrolidine	Chemical	MESH:C032519
34643082	499	509	Pyrazoline	Chemical	-
34643082	510	520	pyrimidine	Chemical	MESH:C030986
34643082	535	552	(3-acetylcoumarin	Chemical	MESH:C094809
34643082	567	601	pyrrolidin-1-yl)benzenesulfonamide	Chemical	-
34643082	612	619	tacrine	Chemical	MESH:D013619
34643082	635	670	(pyrrolidin-1-yl)benzenesulfonamide	Chemical	-
34643082	709	714	COX-2	Gene	4513
34643082	768	775	Tacrine	Chemical	MESH:D013619
34643082	776	787	pyrrolidine	Chemical	MESH:C032519
34643082	811	818	tacrine	Chemical	MESH:D013619
34643082	819	829	pyrimidine	Chemical	MESH:C030986
34643082	1243	1262	compounds 36 and 46	Chemical	-
34643082	1303	1307	AChE	Gene	11423
34643082	1312	1316	BChE	Gene	590
34643082	1377	1389	inflammatory	Disease	MESH:D007249
34643082	1423	1442	compounds 36 and 46	Chemical	-
34643082	1483	1488	edema	Disease	MESH:D004487
34643082	1500	1511	carrageenan	Chemical	MESH:D002351
34643082	1516	1532	arachidonic acid	Chemical	MESH:D016718
34643082	1592	1596	mice	Species	10090
34643082	1617	1624	tacrine	Chemical	MESH:D013619
34643082	1651	1665	hepatotoxicity	Disease	
34643082	1670	1683	neurotoxicity	Disease	MESH:D020258
34643082	1692	1699	SH-SY5Y	CellLine	CVCL:0019
34643082	1700	1713	neuroblastoma	Disease	MESH:D009447
34643082	1734	1739	acute	Disease	MESH:D000208
34643082	1740	1748	toxicity	Disease	MESH:D064420
34643082	Positive_Correlation	MESH:D002351	MESH:D004487
34643082	Negative_Correlation	MESH:C030986	MESH:D009461
34643082	Negative_Correlation	MESH:C030986	4513
34643082	Negative_Correlation	MESH:D013619	MESH:D009447
34643082	Positive_Correlation	MESH:D016718	MESH:D004487
34643082	Negative_Correlation	MESH:C030986	MESH:D000090862
34643082	Association	MESH:D000090862	590
34643082	Association	MESH:C032519	MESH:D000544
34643082	Negative_Correlation	MESH:C030986	MESH:D000544
34643082	Association	MESH:D000090862	4513
34643082	Cotreatment	MESH:C032519	MESH:D013619
34643082	Association	MESH:D002351	MESH:D007249
34643082	Negative_Correlation	MESH:D013619	4513
34643082	Negative_Correlation	MESH:C032519	MESH:D009461
34643082	Association	MESH:D000090862	240
34643082	Association	MESH:D000090862	43
34643082	Negative_Correlation	MESH:C094809	4513
34643082	Negative_Correlation	MESH:C032519	MESH:D000090862

